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Abstract
The complexity of tissue and the alterations that
distinguish normal from cancer remain a challenge for
translating results from tumor biological studies into
clinical medicine. This has generated an unmet need
to exploit the findings from studies based on cell
lines and model organisms to develop, validate and
clinically apply novel diagnostic, prognostic and
treatment predictive markers. As one step to meet
this challenge, the Human Protein Atlas project has
been set up to produce antibodies towards human
protein targets corresponding to all human protein
coding genes and to map protein expression in
normal human tissues, cancer and cells. Here, we
present a dictionary based on microscopy images
created as an amendment to the Human Protein
Atlas. The aim of the dictionary is to facilitate the
interpretation and use of the image-based data
available in the Human Protein Atlas, but also to serve
as a tool for training and understanding tissue
histology, pathology and cell biology. The dictionary
contains three main parts, normal tissues, cancer
tissues and cells, and is based on high-resolution
images at different magnifications of full tissue
sections stained with H & E. The cell atlas is centered
on immunofluorescence and confocal microscopy
images, using different color channels to highlight the
organelle structure of a cell. Here, we explain how
this dictionary can be used as a tool to aid clinicians
and scientists in understanding the use of tissue
histology and cancer pathology in diagnostics and
biomarker studies.
Keywords: Antibody-based proteomics, cancer bio-
markers, tissue and cell dictionary, immunohistochem-
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Background
The Human Protein Atlas project, launched in 2003, was
initiated as a natural extension of the Human Genome
Project, with the objective to explore the proteins encoded
by the human genome. The primary focus was to analyze
the distribution and relative abundance of all proteins in
human normal cells and tissues, and to determine the sub-
cellular localization of each protein. One main goal in this
effort was to contribute to biomedical and clinical
research, and because cancer is a major disease where
diagnostics, classification and prognostic stratification is
based on tissue morphology, a multitude of clinical cancer
tissue samples were included in the comprehensive protein
profiling. This has allowed researchers to utilize the pro-
tein profiling data for both biomarker discovery efforts
and for validation of altered gene expression patterns at
the protein level in both normal and cancer tissue.
The Human Protein Atlas project pursues a systematic
high-throughput generation of affinity-purified polyclonal
antibodies with the aim of generating a map of protein
expression patterns on a proteome-wide scale in both
human normal cells, tissues and organs, and in cancer tis-
sues [1]. Immunohistochemistry (IHC) is performed on
tissue micro arrays (TMA), containing a multitude of dif-
ferent normal tissues and tumors, to enable a comprehen-
sive mapping of protein expression patterns at cellular
resolution in a tissue context. Altogether 144 different nor-
mal tissues are analyzed together with 216 different tumors
representing the 20 most common forms of human cancer
[2]. Immunofluorescence (IF)-based profiling of protein
expression in cell lines is performed to generate a map of
subcellular localization patterns [3]. All protein expression
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data, including the underlying images, are made publicly
available at the Human Protein Atlas web portal (http://
www.proteinatlas.org) [4]. The current version of the
Human Protein Atlas contains data for more than 14,000
unique proteins. This corresponds to more than 70% of all
human protein encoding genes [5].
As the cell constitutes the smallest living entity, it is
required to harbor specialized and distinct subcellular
structures. Cells vary considerably in function and mor-
phology and these differences form the basis for the con-
cept of different cellular phenotypes. On a higher level,
cell types with their distinct phenotypes are organized into
tissues, commonly categorized as epithelial, muscle, vascu-
lar, nervous and connective tissue, and hematopoietic
cells. Genetic changes leading to dysregulated signaling
pathways with altered protein expression patterns cause a
transformation from normal to the phenotypes and mor-
phology that signifies cancer. Cancer is a heterogeneous
disease associated with alterations in protein expression
patterns leading to cell growth and ‘anti-social behavior’ of
tumor cells. The deregulated expression patterns in tumor
cells are caused by genetic and epigenetic alterations lead-
ing to distortion of multiple proteins and signaling path-
ways. Despite the complexity of cancer, microscopic
evaluation of tissue morphology remains the gold standard
for determining a cancer diagnosis in a clinical setting.
Although morphology is crucial, adding a layer of informa-
tion regarding protein expression on top of morphology
appears to be beneficial for the stratification of different
tumor types. Immunohistochemistry prevails as an invalu-
able method to provide such a tool for visualization of
protein expression patterns in cells from a section of
tumor tissue.
The Dictionary - a tool for biomarker studies
The dictionary contains three main parts: normal tissues,
cancer tissues, and cells (http://www.proteinatlas.org/dic-
tionary) (Figure 1). All images and examples include
descriptive text boxes and supporting text with back-
ground information, to facilitate interpretation of the com-
plex patterns underlying normal tissue histology, tumor
pathology and cell biology. H & E-stained tissue sections
have been scanned at 40 × magnification and both normal
and cancer tissues are shown at three different levels of
magnification.
Altogether 45 normal tissue types (represented by 173
images), 20 different cancer types (represented by 193
images) and 18 subcellular structures (represented by
103 images) are included in the dictionary. Examples of
normal tissue show colon (Figure 2A) and breast (Figure
2B) at the three levels of magnification. For cancer, one
case of low-grade (Figure 2C) and one case of high-
grade (Figure 2D) ductal breast cancer is shown. IF and
IHC images representing antibodies targeting proteins
in the nucleoli and the mitochondria demonstrate the
cell structure part (Figure 3). In addition to high resolu-
tion images, there are summarizing descriptive text
paragraphs to supplement the images.
As one of the main goals of this project is to identify
novel biomarkers that can be developed for clinical use,
the 20 types of human cancers illustrated in the dictionary
have also been used for protein profiling in the Human
Protein Atlas. Using the search function at the Human
Protein Atlas portal [6], search strings can be created to
identify candidates for cell or tumor type specific markers
and also proteins differentially expressed within a given
tumor type, thus representing potential prognostic
indicators.
Clinical impact
Successful identification and translation of informative
biomarkers to aid clinical decision-making is a prerequisite
for the implementation of personalized cancer therapeutic
regimens. The antibody-based proteomics strategy
employed in the Human Protein Atlas plays a key role in
the cancer biomarker discovery and validation pipeline,
facilitating evaluation of candidate markers [7]. The newly
launched dictionary provides a useful tool to interpret and
evaluate biomarker candidates identified through various
search strategies in the Human Protein Atlas. The apprai-
sal of protein expression patterns in tumor tissue is a cru-
cial step to select the most promising candidates for
extended experiments, including clinical studies in larger
cohorts, functional studies and in-depth validation of
expression patterns.
The Human Protein Atlas has already been used in
several clinical biomarker studies as a starting point for
exploring both diagnostic and prognostic factors. Cell
and tumor type specific protein expression, critical for
developing diagnostic markers, is exceedingly rare [8],
and only a few such markers exist for clinical use. As an
example, the DNA-binding protein SATB2 was identi-
fied in the Human Protein Atlas as a potential novel
diagnostic marker for colorectal cancer and in an
extended study including more than 2,400 tumors,
SATB2 was found to be both a sensitive and highly spe-
cific marker for colorectal cancer [9]. The basic protein
profiling data available in the Human Protein Atlas has
also allowed for several potential prognostic cancer bio-
markers to be identified for different types of cancer.
This is exemplified by the RNA-binding protein RBM3,
discovered to be a prognostic marker for several differ-
ent forms of cancer [10-12], and also a potential treat-
ment predictive marker for platinum-based therapies
[13]. Understanding of tumor tissue composition is also
fundamental for studies regarding tumor stroma com-
partments. In a recent tumor biology study [14] using a
mouse model, large numbers of granulin-expressing
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bone marrow-derived hematopoietic cells were found in
the tumor stroma of breast cancers responding to insti-
gating signals. This study also showed that the expres-
sion of granulin in human breast cancer was strongly
correlated with the triple negative/basal-like breast
tumor subtypes, and that breast cancer patients with
tumors positive for granulin staining had a significantly
worse outcome in terms of overall survival. The pre-
sented dictionary and Human Protein Atlas can also be
utilized in other clinical research fields, exemplified by
the identification of targets for in vivo imaging of pan-
creatic beta-cells cells in diabetes research [15,16].
Figure 1 Schematic showing the starting page for the dictionary. The three main parts, normal tissues, cancer tissues and cell structures, are
displayed side by side with alphabetical lists below showing the contents of each part to facilitate navigation. All figures are original and
available at the Human Protein Atlas web portal (www.proteinatlas.org/dictionary). Published with permission from the Human Protein Atlas.
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Figure 2 Images showing examples of H & E-stained tissues, including descriptive text boxes, at three different magnifications. Normal
tissue is exemplified by two tissue types. The top overview shows the major components of a normal human colon, followed by higher
magnifications revealing the glandular structure of the mucosa with regularly ordered colonic crypts. The finer details of integrated cells and
structures are apparent at the highest level of magnification (A). The overview of a normal female breast shows the arrangement of included
normal glandular lobules and ducts with magnifications showing a more detailed view of a single lobular unit and details of glandular cells (B).
Cancer is exemplified by two cases of breast cancer. A ductal breast carcinoma with low grade malignancy (Elston-Ellis score 4) from a female
patient age 68 is displayed at three levels of magnification to demonstrate the overall pattern of tumor growth and the finer details of
cancerous glands and details of cancer cells (C). A high grade (Elston-Ellis score 9) ductal breast carcinoma from a female patient age 83 shows
the characteristics of infiltrative tumor growth with poorly differentiated glandular structures and severe cellular atypia (D). All figures are original
and available at the Human Protein Atlas web portal (www.proteinatlas.org/dictionary). Published with permission from the Human Protein Atlas.
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Concluding remarks
Here we present a freely available cell and tissue dictionary
as an amendment to the Human Protein Atlas (reviewed in
[17]) that can be used to facilitate the interpretation of clin-
ical tissue biomarkers. A multitude of high quality images
with supporting short text paragraphs are displayed on the
Human Protein Atlas web portal (http://www.proteinatlas.
org/dictionary) to provide a useful guide for researchers
who are not familiar with the microscopical landscape that
forms the home ground for histologists and pathologists.
In this first version of the dictionary, H & E stained tissue
sections are presented for visualization of normal tissue
and cancer morphology. The essential background needed
to interpret and understand expression data retrieved from
tissues and cells is presented. The aim is to expand the
contents of the dictionary to also include additional levels
of information regarding protein expression so that various
cell populations not distinguishable from morphology
alone can be visualized. Established antibodies can be used
for IHC on consecutive sections of selected tissues to
demonstrate different cell types, for example, B-lympho-
cytes, T-lymphocytes and endothelial cells, and different
cell states, for example, proliferation and differentiation.
Moreover, updates with additional links and text para-
graphs can be added as well as including more examples of
both normal and diseased tissues. For educational pur-
poses, show/hide functionality for text boxes could be
further developed together with sets of relevant ‘Questions
& Answers’. We anticipate that a content rich and knowl-
edge-based cell and tissue dictionary, combined with the
comprehensive map of protein expression patterns in nor-
mal and cancer tissues available through the Human Pro-
tein Atlas, will provide a significant foundation for both
basic and clinical research projects.
Abbreviations
H & E: haematoxylin and eosin; IF: immunofluorescence; IHC:
immunohistochemistry; TMA: tissue micro arrays.
Figure 3 Examples of images demonstrating different organelles in cells. The upper panel shows IF (left and middle) and IHC (right)
images representing the nucleoli, visualized by antibodies targeting proteins expressed in the nucleoli. The nucleoli are shown as a green color
in the IF example and brown color in the IHC example. The lower panel shows images representing mitochondria, visualized by antibodies
expressed in mitochondrion. IF: green - antibody (HPA026512, HPA027999); blue - nucleus (DAPI), red - microtubule. IHC: brown - antibody
(HPA005768, HPA004016). Scalebar 10 μm. IF, immunofluorescence; IHC, immunohistochemistry. All figures are original and available at the
Human Protein Atlas web portal (www.proteinatlas.org/dictionary). Published with permission from the Human Protein Atlas.
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